Suchen
Danaher Corp
DHRZur Watchlist hinzufügen
174.648USD
-26.462-13.16%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
123.60BMarktkapitalisierung
33.63KGV TTM
mehr Informationen über Danaher Corp Unternehmen
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Danaher Corp Informationen
BörsenkürzelDHR
Name des UnternehmensDanaher Corp
IPO-datumJan 16, 2106
CEOBlair (Rainer M)
Anzahl der mitarbeiter61000
WertpapierartOrdinary Share
GeschäftsjahresendeJan 16
Addresse2200 Pennsylvania Ave NW Ste 800W
StadtWASHINGTON
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl20037-1701
Telefon12028280850
Websitehttps://www.danaher.com/
BörsenkürzelDHR
IPO-datumJan 16, 2106
CEOBlair (Rainer M)
Führungskräfte von Danaher Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
+0.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.00M
-2.71%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
87.56K
+2.99%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
19.23K
+11.01%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-29.35%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
9.53K
+34.79%
Mr. Greg Milosevich
Mr. Greg Milosevich
Executive Vice President
Executive Vice President
9.06K
+45.84%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
+0.00%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
33.00M
-2.71%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
87.56K
+2.99%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
87.51K
+46.00%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
40.96K
-1.41%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President
Senior Vice President
22.97K
+1.92%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Danaher Corp?
Die fünf größten Anteilseigner von Danaher Corp sind: Mr. Steven M. Rales
Wie viele Institutionen halten Anteile an Danaher Corp (DHR)?
Mit Stand vom 2026Q1 halten 3953 Institutionen Anteile an Danaher Corp, mit einem Gesamtmarktwert von etwa 594.48M, was 83.99% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -3972448.00 gestiegen.